Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers

Home › Targets › MBNL1

MBNL1 (1 companies · 1 programs)

Companies with an active program directed at MBNL1.

PepGen Inc. PEPG

PGN-EDODM1 — Myotonic Dystrophy Type 1 Phase 2

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.